OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of177Lu-DOTATATE in Neuroendocrine Tumors
Lisa Bodei, Nitya Raj, Richard Kinh Gian, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 4, pp. 567-573
Open Access | Times Cited: 22
Lisa Bodei, Nitya Raj, Richard Kinh Gian, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 4, pp. 567-573
Open Access | Times Cited: 22
Showing 22 citing articles:
Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms
Isabella Reccia, Madhava Pai, Kumar Jayant, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1861-1861
Open Access | Times Cited: 15
Isabella Reccia, Madhava Pai, Kumar Jayant, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1861-1861
Open Access | Times Cited: 15
Theranostics in Neuroendocrine Tumors
Nadine Mallak, Sophia R. O’Brien, Daniel A. Pryma, et al.
The Cancer Journal (2024) Vol. 30, Iss. 3, pp. 185-193
Closed Access | Times Cited: 6
Nadine Mallak, Sophia R. O’Brien, Daniel A. Pryma, et al.
The Cancer Journal (2024) Vol. 30, Iss. 3, pp. 185-193
Closed Access | Times Cited: 6
Update in the management of gastroenteropancreatic neuroendocrine tumors
Andrew J. H. Sedlack, Diana Grace Varghese, Amirkia Naimian, et al.
Cancer (2024) Vol. 130, Iss. 18, pp. 3090-3105
Closed Access | Times Cited: 5
Andrew J. H. Sedlack, Diana Grace Varghese, Amirkia Naimian, et al.
Cancer (2024) Vol. 130, Iss. 18, pp. 3090-3105
Closed Access | Times Cited: 5
Sequencing of Somatostatin-Receptor–Based Therapies in Neuroendocrine Tumor Patients
Jonathan Strosberg, Taymeyah Al‐Toubah, Ghassan El‐Haddad, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 3, pp. 340-348
Open Access | Times Cited: 4
Jonathan Strosberg, Taymeyah Al‐Toubah, Ghassan El‐Haddad, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 3, pp. 340-348
Open Access | Times Cited: 4
Evaluating the prognostic significance of the pre-treatment neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios in 177Lu-DOTATATE PRRT treated patients with advanced metastatic neuroendocrine tumors
Mahesh Kumar Padwal, Amir K Nazar, Rahul V. Parghane, et al.
Endocrine (2025)
Open Access
Mahesh Kumar Padwal, Amir K Nazar, Rahul V. Parghane, et al.
Endocrine (2025)
Open Access
Neuroendocrine Tumors
Lisa Bodei, Vetri Sudar Jayaprakasam, Bernadette Z.Y. Wong, et al.
PET Clinics (2025)
Closed Access
Lisa Bodei, Vetri Sudar Jayaprakasam, Bernadette Z.Y. Wong, et al.
PET Clinics (2025)
Closed Access
Halfdan Sørbye, Geir Olav Hjortland, L. W. Vestermark, et al.
Journal of Neuroendocrinology (2024) Vol. 36, Iss. 11
Open Access | Times Cited: 3
The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms
Catarina Serra-Almeida, Lorenzo Gervaso, Gianmaria Frigè, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3349-3349
Open Access | Times Cited: 3
Catarina Serra-Almeida, Lorenzo Gervaso, Gianmaria Frigè, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3349-3349
Open Access | Times Cited: 3
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force
Vikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 3
Vikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 3
A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to 177Lutetium-DOTA-octreotate radionuclide therapy
Kelly Waldeck, Jessica Van Zuylekom, Carleen Cullinane, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4745-4761
Open Access | Times Cited: 8
Kelly Waldeck, Jessica Van Zuylekom, Carleen Cullinane, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4745-4761
Open Access | Times Cited: 8
Radiopharmaceuticals for Cancer Diagnosis and Therapy
Neil K. Taunk, Freddy E. Escorcia, Jason S. Lewis, et al.
The Cancer Journal (2024) Vol. 30, Iss. 3, pp. 218-223
Closed Access | Times Cited: 2
Neil K. Taunk, Freddy E. Escorcia, Jason S. Lewis, et al.
The Cancer Journal (2024) Vol. 30, Iss. 3, pp. 218-223
Closed Access | Times Cited: 2
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study
Yael Kusne, Terra L. Lasho, Christy Finke, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
Yael Kusne, Terra L. Lasho, Christy Finke, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours
Jelka Kuiper, Eline Zoetelief, Tessa Brabander, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 2
Jelka Kuiper, Eline Zoetelief, Tessa Brabander, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 2
Prediction of 177Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on 68Ga-DOTATATE PET/CT
Hwan Lee, Sarit T. Kipnis, Remy Niman, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 200-200
Open Access | Times Cited: 6
Hwan Lee, Sarit T. Kipnis, Remy Niman, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 200-200
Open Access | Times Cited: 6
Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients
Hao Zhang, Takahiro Tsuchikawa, Satoshi Takeuchi, et al.
Endocrine Journal (2024) Vol. 71, Iss. 9, pp. 873-880
Open Access | Times Cited: 1
Hao Zhang, Takahiro Tsuchikawa, Satoshi Takeuchi, et al.
Endocrine Journal (2024) Vol. 71, Iss. 9, pp. 873-880
Open Access | Times Cited: 1
Genomic Landscape of Pancreatic Neuroendocrine Tumors and Implications for Clinical Practice
Ana De Jesus‐Acosta, Chirayu Mohindroo
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Ana De Jesus‐Acosta, Chirayu Mohindroo
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs
Jonathan M. Loree, David Chan, Jennifer Lim, et al.
JAMA Oncology (2024)
Closed Access | Times Cited: 1
Jonathan M. Loree, David Chan, Jennifer Lim, et al.
JAMA Oncology (2024)
Closed Access | Times Cited: 1
Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time
Stephanie J. Wang, Julia Whitman, Alan Paciorek, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 4
Open Access | Times Cited: 3
Stephanie J. Wang, Julia Whitman, Alan Paciorek, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 4
Open Access | Times Cited: 3
Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
Lisa Bodei, R. Michael Tuttle, Ravinder K. Grewal, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 2, pp. 325-329
Open Access | Times Cited: 3
Lisa Bodei, R. Michael Tuttle, Ravinder K. Grewal, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 2, pp. 325-329
Open Access | Times Cited: 3
Undifferentially Expressed CXXC5 as a Transcriptionally Regulatory Biomarker of Breast Cancer
Xue Li, Xiaoying Lv, Haijun Li, et al.
Advanced Biology (2023) Vol. 7, Iss. 12
Closed Access | Times Cited: 2
Xue Li, Xiaoying Lv, Haijun Li, et al.
Advanced Biology (2023) Vol. 7, Iss. 12
Closed Access | Times Cited: 2
Gene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response
Timothy Smith
Genes (2024) Vol. 15, Iss. 6, pp. 688-688
Open Access
Timothy Smith
Genes (2024) Vol. 15, Iss. 6, pp. 688-688
Open Access
Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies
Nadine Mallak, Burçak Yılmaz, Catherine Meyer, et al.
Current Problems in Cancer (2024) Vol. 52, pp. 101129-101129
Closed Access
Nadine Mallak, Burçak Yılmaz, Catherine Meyer, et al.
Current Problems in Cancer (2024) Vol. 52, pp. 101129-101129
Closed Access
